Refreshing results…
Risk of secondary progressive multiple sclerosis after early worsening of disability
UploadThe risk of secondary progressive multiple sclerosis is geographically determined but modifiable
UploadDisability accrual in primary and secondary progressive multiple sclerosis
UploadComparative effectiveness in multiple sclerosis: A methodological comparison
UploadVariability of the response to immunotherapy among subgroups of patients with multiple sclerosis
UploadConfirmed disability progression as a marker of permanent disability in multiple sclerosis
UploadPrediction of multiple sclerosis outcomes when switching to ocrelizumab
UploadAssociations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
UploadThe effectiveness of natalizumab vs fingolimod–A comparison of international registry studies
UploadDeterminants of therapeutic lag in multiple sclerosis
Download from journals.sagepub.comTreatment response score to glatiramer acetate or interferon beta-1a
UploadEarly clinical markers of aggressive multiple sclerosis
UploadMonitoring of radiologic disease activity by serum neurofilaments in MS
Download from doi.orgMissing publications? Search for publications with a matching author name.